lOMoAR cPSD| 57629747
NR 546 Midterm Practice EXAM
Psychopharmacology
S
Downloaded by Collins Mwaniki ()
, lOMoAR cPSD| 57629747
A 22-year-old patient recently C. Structural factors
diagnosed with bipolar disorder and
states "I'm not crazy" and is refusing
to take his prescribed medication.
Which type of factor is contributing
to this patient's nonadherence?
A.Client factors
B. Clinician factors
C.Structural factors
D.Environmental factors
Using Dell'Osso et al.'s sequential B. Medication education
framework of priorities to promote
medication adherence, determine
which step is being defined: The
PMHNP explains the mechanism of
action, anticipated time to
experience effects, side effects, and
lifestyle instructions to a patient
after prescribing Wellbutrin.
A. Diagnosis
B. Medication education
C. Monitoring plan
D. Adherence reinforcement
A patient recovering from a stroke has D. The Wernicke's area
trouble with speech comprehension
and works with a speech therapist
twice a week. Which part of the
patient's brain has been affected by
the stroke?
A.The Broca's area
B. The Basal ganglia
C.The Limbic system
D. The Wernicke's area
Page 1 of 15
Downloaded by Collins Mwaniki ()
, lOMoAR cPSD| 57629747
Which of the following poses a B. The patient poses a risk to themself as they state they are experiencing
potential ethical concern when very scary auditory and visual hallucinations
prescribing psychiatric medications?
A.The patient is homeless and
uninsured
B. The patient poses a risk to
themself as they state they are
experiencing very scary auditory
and visual hallucinations
C.The patient's family voices a
stigma against psychiatric
medications D. The patient states
they worry about the potential side
effects of the medication
What is the name of the lobe that C. Occipital Lobe
controls visual processing?
A. Gyrus
B. Frontal Lobe
C. Occipital Lobe
D. Parietal Lobe
The cerebellum, cerebrum, brain C. Grey mater
stem, and butterfly-shaped portion
of the central spinal cord
are comprised of
_ which contains neural cell
bodies, axon terminals, dendrites,
and all nerve synapses.
A. Frontal lobe
B. White mater
C. Grey mater
D. Corpus callosum
What is the function of the central B. Separates the frontal from the parietal lobe
sulcus?
A. Separates the temporal from
the occipital lobe
B. Separates the frontal from
the parietal lobe
C. Involved in complex motor
activities
D. Keeps us alert to our
environment
Which of the following is associated D. Thalamus
with motor coordination?
A. Broca's Area
B. Olfactory Nerves
C. Frontal Cortex
D. Thalamus
Page 2 of 15
Downloaded by Collins Mwaniki ()
NR 546 Midterm Practice EXAM
Psychopharmacology
S
Downloaded by Collins Mwaniki ()
, lOMoAR cPSD| 57629747
A 22-year-old patient recently C. Structural factors
diagnosed with bipolar disorder and
states "I'm not crazy" and is refusing
to take his prescribed medication.
Which type of factor is contributing
to this patient's nonadherence?
A.Client factors
B. Clinician factors
C.Structural factors
D.Environmental factors
Using Dell'Osso et al.'s sequential B. Medication education
framework of priorities to promote
medication adherence, determine
which step is being defined: The
PMHNP explains the mechanism of
action, anticipated time to
experience effects, side effects, and
lifestyle instructions to a patient
after prescribing Wellbutrin.
A. Diagnosis
B. Medication education
C. Monitoring plan
D. Adherence reinforcement
A patient recovering from a stroke has D. The Wernicke's area
trouble with speech comprehension
and works with a speech therapist
twice a week. Which part of the
patient's brain has been affected by
the stroke?
A.The Broca's area
B. The Basal ganglia
C.The Limbic system
D. The Wernicke's area
Page 1 of 15
Downloaded by Collins Mwaniki ()
, lOMoAR cPSD| 57629747
Which of the following poses a B. The patient poses a risk to themself as they state they are experiencing
potential ethical concern when very scary auditory and visual hallucinations
prescribing psychiatric medications?
A.The patient is homeless and
uninsured
B. The patient poses a risk to
themself as they state they are
experiencing very scary auditory
and visual hallucinations
C.The patient's family voices a
stigma against psychiatric
medications D. The patient states
they worry about the potential side
effects of the medication
What is the name of the lobe that C. Occipital Lobe
controls visual processing?
A. Gyrus
B. Frontal Lobe
C. Occipital Lobe
D. Parietal Lobe
The cerebellum, cerebrum, brain C. Grey mater
stem, and butterfly-shaped portion
of the central spinal cord
are comprised of
_ which contains neural cell
bodies, axon terminals, dendrites,
and all nerve synapses.
A. Frontal lobe
B. White mater
C. Grey mater
D. Corpus callosum
What is the function of the central B. Separates the frontal from the parietal lobe
sulcus?
A. Separates the temporal from
the occipital lobe
B. Separates the frontal from
the parietal lobe
C. Involved in complex motor
activities
D. Keeps us alert to our
environment
Which of the following is associated D. Thalamus
with motor coordination?
A. Broca's Area
B. Olfactory Nerves
C. Frontal Cortex
D. Thalamus
Page 2 of 15
Downloaded by Collins Mwaniki ()
